Helping SMEs to Innovate
Receive CPI's latest news delivered to your inbox.Sign up to our Mailing List
CPI supports the UK biopharmaceutical industry by engaging in a variety of collaborative work programmes to support process innovation and facilitate the development and adoption of new manufacturing and analytical technologies.
Our capabilities and expertise in high throughput and novel process development enables partners and clients to bring their products to market faster and with reduced risk. We support SMEs, large companies and universities to translate early, proof of concept, stage research in to industry and market-ready technologies.
The National Biologics Manufacturing Centre has been created to act as a central hub for the UK’s Biologics industry, hosting key events and research projects and providing a central facility to advance innovation in the industry.
Our core themes are:
We offer services in the following areas:
Through our range of technology development services and our Industrial Biotechnology facility, we help our clients to de-risk process development and provide proof-of-concept testing at scale.
Our multidisciplinary team has completed feasibility assessments, process development projects and piloting studies for UK, European and international clients.
In order to maximise our value to clients we offer a range of services to help to speed up product and process development and provide the most robust manufacturing proof of concept packages. CPI can help commercialise your ideas and take them to market faster and with minimal risk.
We have the capability to deliver both in depth development programs using our range of technology development services as well as less complex projects with a simple goal.
Our facilities and expertise provide clients with the environment to understand how their products and processes perform under manufacturing conditions and accelerate their commercial realisation.
CPI focuses on the integration and manufacturing of new innovative electronic devices, developing the technologies that will drive the manufacturing process forward. These new processes, including the printing of electronic functionality, open up a host of design opportunities and will lead to the creation of a range of future electronic applications in key market sectors such as print and packaging, healthcare, built environment, automotive and aerospace.
CPI is supporting innovation in the biopharmaceutical industry, helping the UK to remain competitive in a global marketplace.
We enable ideas, research and knowledge to be translated into commercial business propositions by providing the facilities and technical expertise to help companies overcome their innovation challenges.
Utilising the National Biologics Manufacturing Centre, CPI can help companies of all sizes to understand the technical feasibility of their new biologic process or technology, helping to get it to market faster and with less risk.
CPI’s National Formulation Centre is a UK based open-access innovation centre for advanced formulated product design and manufacture.
The centre is industry driven and brings together world class cross sector expertise, technology and infrastructure to provide the environment for companies to increase productivity and accelerate the commercialisation of their next generation formulated products.
The National Formulation Centre is managed by CPI and operates a hub and spoke model to deliver bigger, cheaper and faster innovation into UK manufacturing. The model brings together multiple innovation supply chains and world leading capability in the design and mechanistic understanding of complex formulated systems. Working with the centre, clients can substantially increase the speed of innovation as well as necessitating a significant reduction in the risks and costs associated with new product development.